Clinical trial Recruiting at 1 site Interventional Ages 60 to 90

Multi-omics analysis of iNPH and ventriculoperitoneal shunt outcomes

Official title: Multi-omics Research of Prognostic Factors of Ventriculoperitoneal Shunt for Idopathic Normal Pressure Hydrocephalus

Run by Second Affiliated Hospital, Zhejiang University, School of Medicine · NCT04998175 · Data updated 2026-11-12

This project will test whether changes in cerebrospinal fluid proteins and brain MRI before and after a ventriculoperitoneal shunt can help predict recovery for people aged 60 and older with idiopathic normal pressure hydrocephalus.

Quick facts

Study typeInterventional
Ages60 Years to 90 Years
SexAll
Enrollment40 (estimated)
SponsorSecond Affiliated Hospital, Zhejiang University, School of Medicine
Academic / other
Locations1 site (Hangzhou, Zhejiang)
StatusRecruiting
StartedSeptember 15, 2020
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedApril 24, 2026
Trial IDNCT04998175 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

People aged 60 or older with a clinical diagnosis of idiopathic normal pressure hydrocephalus who can give informed consent and are medically eligible for VP shunt surgery.

Probably not a fit

Patients with secondary NPH, concurrent Alzheimer’s or Parkinson’s disease, or those who are not medically fit for shunt surgery are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants undergo preoperative T1-weighted, functional, and diffusion MRI and clinical assessments including MMSE, gait scores, Kiefer score, and modified Rankin Scale before and after a lumbar tap test and again six months after VP shunt surgery. Cerebrospinal fluid is collected at the tap test and from the VP device pump six months post‑surgery for proteomic analysis. The study combines CSF proteomics with structural and functional MRI analyses to identify biological and imaging prognostic factors linked to shunt response. Data are collected at The Second Affiliated Hospital, School of Medicine, Zhejiang University with Westlake University collaboration.

Why it matters

Potential benefit: If successful, the work could help doctors predict who is most likely to improve after VP shunt and guide surgical decisions.

How similar studies have gone: Prior small studies have linked CSF biomarkers and specific MRI features to shunt response, but comprehensive multi-omics prognostic models for iNPH remain limited and relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 60 years;
* Diagnosis of iNPH based on clinical assessment
* Participant is able to give written informed consent

Exclusion Criteria:

* Combining AD and Parkinson's disease and other nervous system diseases
* Participant is not medically available for shunt surgery
* Secondary NPH

Where it's running

  • The second affliated hospital of zhejiang university
    Hangzhou, Zhejiang, China
    Recruiting

Study contacts

  • Principal investigator: Zhoule Zhu — Second Affiliated Hospital, Zhejiang University, School of Medicine
  • Study coordinator: Junming Zhu, M.D.
  • Email: dr.zhujunming@zju.edu.cn
  • Phone: 86-13968055768

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Combining tests and scans to improve diagnosis and surgery decisions in idiopathic normal pressure hydrocephalus

    This project will try combining memory and gait tests, spinal fluid markers, and brain MRI to see if that helps identify people over 60 with suspected iNPH who are likely to benefit from shunt surgery.

    Recruiting Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Milan and 1 other locations · NCT07427836

  • Understanding the clinical outcomes of idiopathic normal pressure hydrocephalus

    This study is trying to learn more about idiopathic normal pressure hydrocephalus and its progression by looking at different tests and samples from people with the condition to help improve diagnosis and treatment.

    Recruiting Xuanwu Hospital, Beijing · Beijing, Beijing Municipality · NCT06428734

  • Intelligent Video Laryngoscope to Help Emergency Intubations

    A smart video laryngoscope with AI is tested to help doctors place tubes in critically ill adults needing emergency intubation.

    Recruiting at 2 sites Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang and 1 other locations · NCT07922044

  • Understanding anxiety, depression, and bipolar disorder over time in China

    This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.

    Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07903246

  • Ultrasound-guided nasal bone fracture reduction

    This study tests whether using ultrasound to guide nasal bone fracture reduction can improve accuracy and outcomes for people with recent nasal injuries.

    Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang and 1 other locations · NCT07869563

  • Simplified Tranexamic Acid Regimen for Trauma with Hemorrhage

    This trial tests a simplified TXA dosing approach to see if it safely helps adults with major trauma and significant bleeding.

    Recruiting at 3 sites Phase 4 Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang and 2 other locations · NCT07869537

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.